MBX
MBX Biosciences, Inc.
57.72
+1.39 (+2.47%)
52w low 23.07
72.64 high
69.9% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | -- | 39.78M | 223.12M | 75.29M | 45.21M | 54.12M | |
| Receivables | -- | 841.00K | 1.55M | 2.12M | 3.16M | 3.04M | |
| Current Assets | -- | 229.19M | 397.50M | 381.54M | 448.54M | 427.86M | |
| Net PP&E | -- | 2.28M | 2.52M | 3.22M | 3.59M | 7.42M | |
| Total Assets | -- | 231.52M | 400.08M | 385.14M | 452.70M | 435.91M | |
| Current Liabilities | -- | 11.76M | 12.06M | 15.49M | 14.57M | 23.66M | |
| Total Debt | -- | 650.00K | 623.00K | 596.00K | 555.00K | 3.34M | |
| Total Liabilities | -- | 12.28M | 12.54M | 15.92M | 14.95M | 26.37M | |
| Retained Earnings | -- | -180.80M | -202.41M | -224.48M | -247.99M | -285.09M | |
| Shareholders Equity | -- | 219.24M | 387.54M | 369.22M | 437.76M | 409.54M | |
| Working Capital | -- | 217.43M | 385.44M | 366.04M | 433.97M | 404.20M | |
| Shares Outstanding | -- | 33.59M | 44.72M | 44.93M | 47.57M | 47.95M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--